Transaction in Own Shares

Reckitt Benckiser Group PLC
08 November 2023
 

Transaction in own shares

 

Reckitt Benckiser Group plc (the "Company") announces today it has purchased the following number of its ordinary shares of 10 pence each ("shares") from Morgan Stanley & Co. International Plc in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 3 May 2023 (the "Purchase"). The Purchase was effected pursuant to instructions issued by the Company on 29 October 2023, as announced on 30 October 2023. The repurchased shares will be held in treasury.

 

Ordinary Shares

 

Date of purchase:

7 November 2023

Aggregate number of ordinary shares purchased:

77,469

Highest price paid per share (pence):

5,536.00

Lowest price paid per share (pence):

5,480.00

Volume weighted average price paid per share (pence):

5,507.54

 

Following settlement of the above transaction, the Company will hold 19,526,524 of its ordinary shares in treasury and have 717,008,655 ordinary shares in issue (excluding treasury shares).

 

Therefore, the total number of voting rights in the Company will be 717,008,655 and this figure may be used by shareholders as the denominator when determining whether they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

In accordance with Article 5(1)(b) of the Market Abuse Regulation (EU) No 596/2014 as it applies in the UK, a full breakdown of the individual trades made by the Broker on behalf of the Company is detailed below: 

 

http://www.rns-pdf.londonstockexchange.com/rns/7041S_1-2023-11-7.pdf 

 

 

This announcement does not constitute, or form part of, an offer or any solicitation of an offer for securities in any jurisdiction.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings